Karyopharm Therapeutics Inc. (KPTI) Social Stream
KARYOPHARM THERAPEUTICS INC (KPTI) Price Targets From Analysts
Use the tables below to see what analysts covering KARYOPHARM THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-04 | 8 | $35 | $6 | $17.714 | $0.833 | 2026.53% |
| 2021-11-19 | 8 | $35 | $6 | $15.285 | $0.833 | 1734.93% |
| 2021-12-21 | 8 | $35 | $6 | $15.571 | $0.833 | 1769.27% |
| 2022-02-01 | 8 | $35 | $8 | $16 | $0.833 | 1820.77% |
| 2022-02-09 | 8 | $35 | $8 | $16.428 | $0.833 | 1872.15% |
| 2022-03-02 | 8 | $35 | $8 | $14.875 | $0.833 | 1685.71% |
| 2022-03-18 | 8 | $22 | $6 | $11.714 | $0.833 | 1306.24% |
| 2022-04-12 | 7 | $22 | $6 | $11.714 | $0.833 | 1306.24% |
| 2022-05-06 | 7 | $22 | $6 | $11.5 | $0.833 | 1280.55% |
| 2022-07-14 | 7 | $21 | $5 | $10.875 | $0.833 | 1205.52% |
| 2022-08-04 | 9 | $18 | $5 | $10.5 | $0.833 | 1160.5% |
| 2022-08-05 | 8 | $18 | $5 | $10.1 | $0.833 | 1112.48% |
| 2022-10-20 | 8 | $18 | $5 | $9.8 | $0.833 | 1076.47% |
| 2022-11-04 | 9 | $18 | $5 | $9.9 | $0.833 | 1088.48% |
| 2022-12-13 | 9 | $18 | $5 | $9.7 | $0.833 | 1064.47% |
| 2023-01-10 | 9 | $16 | $5 | $9.3 | $0.833 | 1016.45% |
| 2023-01-19 | 10 | $16 | $5 | $9.181 | $0.833 | 1002.16% |
| 2023-02-15 | 9 | $16 | $5 | $9 | $0.833 | 980.43% |
| 2023-03-30 | 10 | $16 | $5 | $9.4 | $0.833 | 1028.45% |
| 2023-04-19 | 10 | $16 | $5 | $9.333 | $0.833 | 1020.41% |
| 2023-05-04 | 10 | $16 | $5 | $9 | $0.833 | 980.43% |
| 2023-05-08 | 10 | $14 | $5 | $8.1 | $0.833 | 872.39% |
| 2023-07-26 | 10 | $14 | $5 | $7.7 | $0.833 | 824.37% |
| 2023-08-03 | 10 | $14 | $4 | $7.2 | $0.833 | 764.35% |
| 2023-08-04 | 9 | $10 | $4 | $6.125 | $0.833 | 635.29% |
| 2023-10-25 | 9 | $10 | $4 | $5.875 | $0.833 | 605.28% |
| 2023-11-03 | 10 | $10 | $3 | $5.5 | $0.833 | 560.26% |
The Trend in the Analyst Price Target
Over the past 19 months, KPTI's average price target has gone down $5.88.
KPTI reports an average of 326.42% for its upside potential over the past 42 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-16 | 10 | 16 | 5 | 9.000 | 3.59 | 150.7% |
| 2023-03-30 | 10 | 16 | 5 | 9.400 | 3.52 | 167.05% |
| 2023-10-20 | 9 | 10 | 4 | 5.875 | 1.06 | 454.25% |
| 2023-11-03 | 10 | 10 | 3 | 5.500 | 0.89 | 517.98% |
| 2023-11-03 | 10 | 10 | 3 | 5.333 | 0.89 | 499.21% |
KPTI Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.78 | 5 | 1 | 3 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
KPTI's average broker recommendation rating worsened by 0.2 over the prior 41 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- KARYOPHARM THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 3688.42% of all US stocks.
- In terms of how KARYOPHARM THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -3481.17% of that group.
- KARYOPHARM THERAPEUTICS INC's number of analysts covering the stock is greater than 3519.29% of stocks in the small market cap category.
- To contextualize these metrics, consider that out of Healthcare stocks, KARYOPHARM THERAPEUTICS INC's average analyst price target is higher than 665.05% of them.
Stocks similar to KARYOPHARM THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are TVTX, FBIO, and ASMB.
View All Top Stocks by Price Target
Is KPTI a Buy, Hold or Sell? See the POWR Ratings now!